Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptors

European Journal of Pharmacology

Volumn 351, Issue 2, 1998, Pages 235-246

  Geiger, Jörg ^a   Hönig Liedl, Petra ^a   Schanzenbächer, Peter ^a   Walter, Ulrich ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

ADP derivative; Ca2+; G protein; Purinoceptor; Thienopyridine

Indexed keywords

ADENOSINE DERIVATIVE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; NUCLEOTIDE DERIVATIVE; PURINE RECEPTOR; RECEPTOR PROTEIN; RECEPTOR SUBTYPE; SURAMIN; TICLOPIDINE;

ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DESENSITIZATION; DRUG SENSITIVITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; NORMAL HUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; THROMBOCYTE; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; ADENYLATE CYCLASE; BLOOD PLATELETS; CALCIUM; HUMANS; ION TRANSPORT; LIGANDS; PLATELET AGGREGATION INHIBITORS; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION; TICLOPIDINE;

EID: 0345368067     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00305-7     Document Type: Article

References (35)

1. Born, G.V.R., 1985. Adenosine diphosphate as a mediator of platelet aggregation in vivo: an editorial point of view. Circulation 72, 741-742.
2. CAPRIE Steering Committee, 1996. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348, 1329-1339.
3. Cole, B., Robinson, G.P., Hartmann, R.C., 1971. Studies on the role of cyclic AMP in platelet function. Ann. NY Acad. Sci. 185, 477-487.
4. Daniel, J.L., Dangelmaier, C., Jin, J., Ashby, B., Smith, J.B., Kunapuli, S.P., 1998. Molecular basis for ADP-induced platelet activation (I). J. Biol. Chem. 273, 2024-2029.
5. 2X purinoceptors). Mol. Pharmacol. 48, 178-183.
6. 2 receptors. Trends Pharmacol. Sci. 18, 79-82.
7. Gaardner, A., Jonsen, J., Laland, S., Hellem, A., Owen, P.A., 1961. Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature 192, 531-532.
8. Gachet, C., Hechler, B., Léon, C., Vial, C., Leray, C., Ohlmann, P., Cazenave, J.-P., 1997. Activation of ADP receptors and platelet function. Thromb. Haemost. 78, 271-275.
9. Geiger, J., Walter, U., 1993. Properties and regulation of human platelet cation channels. EXS 66, 281-288.
10. Geiger, J., Nolte, C., Walter, U., 1994. Regulation of calcium mobilization and entry in human platelets by endothelium derived factors. Am. J. Physiol. 267, C236-C244.
11. Geiger, J., Nolte, C., Butt, E., Sage, S.O., Walter, U., 1992. Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets. Proc. Natl. Acad. Sci. USA 89, 1031-1035.
12. Horstrup, K., Jablonka, B., Hönig-Liedl, P., Just, M., Kochsiek, K., Walter, U., 1994. Phosphorylation of the focal adhesion protein vasodilator stimulated phosphoprotein at serine 157 in intact human platelets correlates with fibrinogen receptor inhibition. Eur. J. Biochem. 225, 21-27.
13. Hourani, S.M., Hall, D.A., 1994. Receptors for ADP on human blood platelets. Trends Pharmacol. Sci. 15, 103-108.
14. Jin, J., Daniel, J.L., Kunapuli, S.P., 1998. Molecular basis for ADP-induced platelet activation (II). J. Biol. Chem. 273, 2030-2034.
15. 2X purinoceptors be classified pharmacologically?. Trends Pharmacol. Sci. 16, 168-174.
16. Koesling, D., Nürnberg, B., 1997. Platelet G proteins and adenylyl and guanylyl cyclases. In: von Bruchhausen, F., Walter, U. (Eds.), Handbook of Experimental Pharmacology, Vol. 126, Platelets and Their Factors, Springer, Berlin, pp. 181-218.
17. 2T purinoceptors in human platelets. J. Biol. Chem. 271, 2879-2881.
18. Mahaut-Smith, M.P., Sage, S.O., Rink, T.J., 1992. Rapid ADP-evoked currents in human platelets recorded with the nystatin permeabilized patch technique. J. Biol. Chem. 267, 3060-3065.
19. Markert, T., Bertsch, G., Langenfeld, H., Schanzenbächer, P., 1996. Elective coronary implantation of a new stent without conventional anticoagulation. Dtsch. Med. Wochenschr. 121, 1213-1219.
20. 2X purinoceptors. Mol. Pharmacol. 51, 524-532.
21. Mills, D.C.B., 1996. ADP receptors on platelets. Thromb. Haemost. 76, 835-856.
22. North, R.A., Barnard, E.A., 1997. Nucleotide receptors. Curr. Opin. Neurobiol. 7, 346-357.
23. α(q)-deficient mice. Nature 389, 183-186.
24. i2 proteins. Biochem. J. 312, 775-779.
25. 2X3 receptors. J. Neurosci. 17, 6529-6533.
26. Rink, T.J., Sage, S.O., 1990. Calcium signaling in human platelets. Annu. Rev. Physiol. 52, 431-449.
27. 2+-influx in Fura-2-loaded human platelets. Biochem. J. 265, 675-680.
28. Savi, P., Heilmann, E., Nurden, P., Laplace, M.-C., Bihour, C., Kieffer, G., Nurden, A.T., Herbert, J.-M., 1996. Clopidogrel: an antithrombotic drug acting on the ADP-dependent activation pathway of human platelets. Clin. Appl. Thromb. Haemost. 2, 35-42.
29. 2Y1 purinoceptor in ADP-induced platelet activation. FEBS Lett. 422, 291-295.
30. 2Y1-purinoceptor. Brit. J. Pharmacol. 118, 167-173.
31. Schrör, K., 1993. The basic pharmacology of ticlopidine and clopidogrel. Platelets 4, 252-261.
32. Thomason, P.A., James, S.R., Casey, P.J., Downes, C.P., 1994. A G-protein βγ-subunit-responsive phosphoinositide 3-kinase activity in human platelet cytosol. J. Biol. Chem. 269, 16525-16528.
33. 2X receptor for extracellular ATP. Nature 371, 516-519.
34. 2Y3) activated preferentially by nucleoside diphosphates. Mol. Pharmacol. 50, 258-265.
35. Zhang, J., Zhang, J., Shattil, S.J., Cunningham, M.C., Rittenhouse, S.E., 1996. Phosphoinositide 3-kinase γ and p85/phosphoinositide 3-kinase in platelets. J. Biol. Chem. 271, 6265-6272.